StockData
ELI LILLY & Co logo

ELI LILLY & Co

LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)

Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%

Eli Lilly Construction in progress (CIP by Year

Construction in progress (CIP — manufacturing capacity expansion), gross ($M) ($M)

Eli Lilly Construction in progress (CIP: $13,013M in FY2025, up 57.8% from a year earlier. That is the highest of the 10 years on record here.

Latest, FY2025
13,013
Period ended Dec 31, 2025
Change on a year earlier
+57.8%
8,245 in FY2024
History
10 years
Since FY2016
Sources
9
Documents cited below

Where the FY2025 figure comes from

Source: Form 10-K (filed 2026-02-12) ↗

Reported in Form 10-K Property & Equipment Note.

Annual history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConstruction in progress (CIP — manufacturing capacity expansion), gross ($M) ($M)Year on yearSource
FY2025Dec 31, 202513,013+57.8%Form 10-K (filed 2026-02-12) ↗
FY2024Dec 31, 20248,245+62.2%Form 10-K (filed 2026-02-12) ↗
FY2023Dec 31, 20235,084+81.7%Form 10-K (filed 2025-02-19) ↗
FY2022Dec 31, 20222,799+28.5%Form 10-K (filed 2024-02-21) ↗
FY2021Dec 31, 20212,178+1.8%Form 10-K (filed 2023-02-22) ↗
FY2020Dec 31, 20202,139+13.5%Form 10-K (filed 2022-02-23) ↗
FY2019Dec 31, 20191,884+18.6%Form 10-K (filed 2021-02-17) ↗
FY2018Dec 31, 20181,589-10.9%Form 10-K (filed 2020-02-19) ↗
FY2017Dec 31, 20171,784-0.8%Form 10-K (filed 2019-02-19) ↗
FY2016Dec 31, 20161,798–Form 10-K (filed 2018-02-20) ↗

Cite this data

StockData. (2026). Eli Lilly Construction in progress (CIP ($M), annual FY2016–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/ppe-cip

See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.